In the context of HCC, tumor-infiltrating NK cells express higher levels of CD49a compared to their liver-resident counterparts (5), and this phenotype is associated with poor prognosis (6, 7), suggesting a potential role for CD49a+ NK cells in promoting immune evasion and tumor progression. The gene discussed is ITGA1; the disease is hepatocellular carcinoma.